Longeveron News

Longeveron Analyst Ratings

BenzingaNov 25 21:50

H.C. Wainwright Maintains Longeveron(LGVN.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 25 19:33

Longeveron Analyst Ratings

BenzingaNov 4 19:40

H.C. Wainwright Maintains Longeveron(LGVN.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 4 19:33

Longeveron Analyst Ratings

BenzingaSep 4 19:00

Buy Rating Affirmed for Longeveron on Favorable Lomecel-B Regulatory Outlook and Trial Progress

TipRanksSep 4 18:31

H.C. Wainwright Maintains Longeveron(LGVN.US) With Buy Rating, Maintains Target Price $10

Futu NewsSep 4 18:31

Maxim Group Maintains Longeveron(LGVN.US) With Buy Rating, Cuts Target Price to $6

Futu NewsAug 28 02:31

Longeveron Price Target Cut to $6.00/Share From $15.00 by Maxim Group

Dow JonesAug 27 22:33

Longeveron Is Maintained at Buy by Maxim Group

Dow JonesAug 27 22:33

Longeveron Analyst Ratings

BenzingaAug 27 22:24

Maxim Group Maintains Buy on Longeveron, Lowers Price Target to $6

BenzingaAug 27 22:24

Maxim Group Maintains Longeveron(LGVN.US) With Buy Rating, Cuts Target Price to $6

Futu NewsAug 27 21:31

HC Wainwright & Co. Reiterates Buy on Longeveron, Maintains $10 Price Target

BenzingaAug 15 19:38

H.C. Wainwright Maintains Longeveron(LGVN.US) With Buy Rating, Maintains Target Price $10

Futu NewsAug 15 18:35

Buy Rating Reaffirmed for Longeveron on Strong Clinical Trial Prospects and Regulatory Advantages

TipRanksAug 15 18:32

Longeveron Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow JonesJul 31 19:59

Longeveron Analyst Ratings

BenzingaJul 31 19:54

HC Wainwright & Co. Reiterates Buy on Longeveron, Maintains $10 Price Target

BenzingaJul 31 19:53

H.C. Wainwright Maintains Longeveron(LGVN.US) With Buy Rating, Maintains Target Price $10

Futu NewsJul 31 18:34